Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis.

Brian D KentGrainne d'AnconaMariana FernandesLinda GreenCris RoxasLouise ThomsonAlexandra M NanzerJoanne KavanaghSangita AgarwalAlexandra M Nanzer

Published in: ERJ open research (2020)

Blockade of interleukin-5 with reslizumab appears to have significant oral corticosteroid sparing effects in patients with eosinophilic granulomatosis with polyangiitis and severe eosinophilic asthma http://bit.ly/2D2yYSK.

Keyphrases

chronic rhinosinusitis
robot assisted
chronic obstructive pulmonary disease
lung function
drug induced